From Oxford to the World

We found, fund and build for tomorrow’s challenges, today

Meet our companies

Oxford Science Enterprises (OSE) was founded in 2015 with a big ambition: to bring Oxford’s best ideas to the world and solve our greatest challenges at unprecedented speed.

Seven years ago OSE was just an idea. Today we are an independent, billion-pound investment company that creates transformational businesses via our unique partnership with the University of Oxford, the world’s #1 research university. ​

Together with Oxford University we’ve helped create a phenomenal science-business ecosystem, increasing investment in university spinouts from an average of £125m per year (2011-2015) to £1.4bn in 2021, while attracting an impressive influx of scientific and management talent from around the world.

Across our three sectors, we are the first cheque in and back our companies all the way to exit

Deep Tech
We develop foundational new technologies that will fuel the fourth industrial revolution.
Life Sciences
We partner with scientific luminaries to translate novel research into new medicines that improve patients’ lives.
Health Tech
We back pioneers at the intersection of health and technology, powering the rise in adoption of digital tools.
Raised over£850m 
InThreeHigh-impact sectors
that have resulted in
Over 40Core portfolio COS
7 Exits 

Featured News

View all news
DJS Antibodies to be acquired by AbbVie
DJS Antibodies to be acquired by AbbVie
MiroBio to be acquired by Gilead Sciences for approximately $405 million
Oxford Science Enterprises raises £250 million
Oxford Science Enterprises raises £250 million
Article links to
First Light Fusion
First Light Fusion achieves world first fusion result, proving unique new target technology